Literature DB >> 2650908

Characterization of the human cell line TE671.

M R Stratton1, J Darling, G J Pilkington, P L Lantos, B R Reeves, C S Cooper.   

Abstract

The cell line TE671 has been widely used as a model of human medulloblastoma. In the present study we have demonstrated that transfection of DNA from this cell line into NIH 3T3 cells reveals the presence of an activated N-ras gene. Using oligonucleotide probes we have shown that the N-ras gene is activated by a point mutation at the third base of codon 61 resulting in the substitution of histidine for glutamine in the p21 ras gene product. We noted that this relatively uncommon activating mutation is also present in the human rhabdomyosarcoma cell line RD. Based on this finding and on the observation that several of the phenotypic characteristics of TE671, such as the presence of muscle-type nicotinic acetylcholine receptors and the intermediate filament protein desmin, are suggestive of myoid origin we investigated the possible identity of these two cell lines. Cytogenetic analysis revealed the presence of marker chromosomes common to both TE671 and RD. DNA fingerprinting using both locus specific and multilocus core probes showed indistinguishable band patterns in the two cell lines. Taken together our data show that TE671 and RD are derivatives of the same cell line and we conclude that the properties of the TE671 line should be ascribed to rhabdomyosarcoma rather than medulloblastoma cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2650908     DOI: 10.1093/carcin/10.5.899

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  37 in total

1.  Bipolar (neural and myoblastic) phenotype in cell lines derived from human germ cell tumours of testis.

Authors:  S Navarro; R Noguera; A Peydró-Olaya; A Llombart-Bosch
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

Review 2.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

3.  Cerebellar medullomyoblastoma with advanced neuronal differentiation and hamartomatous component.

Authors:  T Höll; P Kleihues; M G Yasargil; O D Wiestler
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  A novel chemical screening strategy in zebrafish identifies common pathways in embryogenesis and rhabdomyosarcoma development.

Authors:  Xiuning Le; Emily K Pugach; Simone Hettmer; Narie Y Storer; Jianing Liu; Airon A Wills; Antony DiBiase; Eleanor Y Chen; Myron S Ignatius; Kenneth D Poss; Amy J Wagers; David M Langenau; Leonard I Zon
Journal:  Development       Date:  2013-04-24       Impact factor: 6.868

5.  A confocal scanning laser microscope for quantitative ratiometric 3D measurements of [Ca2+] and Ca2+ diffusions in living cells stained with Fura-2.

Authors:  P J Helm; O Franksson; K Carlsson
Journal:  Pflugers Arch       Date:  1995-03       Impact factor: 3.657

6.  Lovastatin-induced apoptosis of human medulloblastoma cell lines in vitro.

Authors:  R J Macaulay; W Wang; J Dimitroulakos; L E Becker; H Yeger
Journal:  J Neurooncol       Date:  1999-03       Impact factor: 4.130

Review 7.  Medulloblastoma: molecular genetics and animal models.

Authors:  Corey Raffel
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

8.  Cholinergic responses in cloned human TE671/RD tumour cells.

Authors:  F Grassi; A Giovannelli; S Fucile; E Mattei; F Eusebi
Journal:  Pflugers Arch       Date:  1993-10       Impact factor: 3.657

9.  Expression and ligand-binding function of the integrin alpha 4 beta 1 (VLA-4) on neural-crest-derived tumor cell lines.

Authors:  J L Bednarczyk; B W McIntyre
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

10.  Interaction between human medulloblastomas and foetal rat brain aggregates in vitro.

Authors:  A J Terzis; H Arnold; O D Laerum; R Bjerkvig
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.